|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-1-18
|
|
pubmed:abstractText |
Previous studies suggested that in patients with thalassemia major, initiating deferoxamine (DFO) therapy before puberty can prevent iron-induced failure of growth and puberty. However, early initiation of chelation has also been associated with DFO toxicity. The aim of this retrospective study was to determine the prevalence rates of endocrine complications and DFO bone toxicity in our thalassemia major patients and to correlate them with the degree of iron chelation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0902-4441
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) Blackwell Munksgaard 2005
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
93-100
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15654898-Adolescent,
pubmed-meshheading:15654898-Adult,
pubmed-meshheading:15654898-Biological Markers,
pubmed-meshheading:15654898-Body Height,
pubmed-meshheading:15654898-Child,
pubmed-meshheading:15654898-Child, Preschool,
pubmed-meshheading:15654898-Deferoxamine,
pubmed-meshheading:15654898-Female,
pubmed-meshheading:15654898-Ferritins,
pubmed-meshheading:15654898-Growth Disorders,
pubmed-meshheading:15654898-Humans,
pubmed-meshheading:15654898-Hypogonadism,
pubmed-meshheading:15654898-Infant,
pubmed-meshheading:15654898-Iron,
pubmed-meshheading:15654898-Iron Chelating Agents,
pubmed-meshheading:15654898-Male,
pubmed-meshheading:15654898-Prognosis,
pubmed-meshheading:15654898-Puberty,
pubmed-meshheading:15654898-Retrospective Studies,
pubmed-meshheading:15654898-Risk Factors,
pubmed-meshheading:15654898-beta-Thalassemia
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
|
|
pubmed:affiliation |
Institute for Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
|
|
pubmed:publicationType |
Journal Article
|
